Nakaseomyces glabratus
Nakaseomyces glabratus is a species of yeast in the family Saccharomycetaceae. It is a fungus that is commonly found in the environment, particularly in soil and on plants. It is also known to be a part of the normal microbiota in humans and animals.
Taxonomy[edit]
The genus Nakaseomyces was first described in 1995 by Masako Takashima and Junta Sugiyama. The species Nakaseomyces glabratus was first described in 2003 by Marc-André Lachance and Carlos A. Rosa. The genus name Nakaseomyces is in honor of the Japanese mycologist Takuo Nakase, while the species name glabratus is derived from the Latin word for "smooth", referring to the smooth appearance of the yeast cells.
Characteristics[edit]
Nakaseomyces glabratus is a haploid yeast, meaning it has a single set of chromosomes. It is capable of both asexual reproduction through budding and sexual reproduction through the formation of ascospores. The yeast cells are oval in shape and are typically 2-5 micrometers in diameter.
Ecology[edit]
Nakaseomyces glabratus is a mesophilic yeast, meaning it grows best at moderate temperatures. It is commonly found in soil and on plants, but can also be found in the gastrointestinal tract of humans and animals. It is not known to cause disease in healthy individuals, but can cause opportunistic infections in individuals with weakened immune systems.
Genomics[edit]
The genome of Nakaseomyces glabratus has been sequenced, revealing a compact genome of approximately 12 million base pairs. The genome contains around 5,000 predicted genes, many of which are involved in fermentation, sugar metabolism, and stress response.
Research[edit]
Nakaseomyces glabratus is used as a model organism in research due to its ease of cultivation and genetic manipulation. It is particularly useful in studies of yeast evolution, genetics, and metabolism.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
